Regulations.gov document
Draft Guidance for Industry; Availability: Chronic Hepatitis C Virus Infection; Developing…
Notice · FDA-2010-D-0462 · posted Sep 14, 2010
Key facts
| Document ID | FDA-2010-D-0462-0001 |
|---|---|
| Title | Draft Guidance for Industry; Availability: Chronic Hepatitis C Virus Infection; Developing Direct-Acting Antiviral Agents forTreatment |
| Document type | Notice |
| Subtype | NAD-Notice of Availability of Data |
| Agency | FDA |
| Docket | FDA-2010-D-0462 |
| Posted | Sep 14, 2010 |
| Federal Register citation | 75 FR 55797 |
| FR document number | 2010-22806 |
| Comment period opens | Sep 14, 2010 |
| Comments due | Nov 16, 2010 |
| Effective date | Sep 14, 2010 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: